Dextropropoxyphene produces 30 documented subjective effects across 2 categories.
Full Dextropropoxyphene profileDextropropoxyphene is an opioid of modest ambitions. Its onset unfolds over forty-five minutes to an hour, arriving not with any particular fanfare but with a quiet, almost apologetic warmth that settles into the body like a lukewarm bath. The first signs are easy to miss: a faint relaxation in the jaw, a subtle easing of whatever minor aches had been occupying your attention. There is no rush, no wave, no moment of dramatic transition -- just a slow, incremental softening of the body's baseline discomfort.
At its peak, dextropropoxyphene delivers a mild but genuine comfort. The warmth is present but thin, spread across the body in an even layer that lacks the depth and intensity of stronger opioids. There is a gentle drowsiness, a pulling-down of the eyelids that suggests sleep without insisting upon it. The emotional landscape shifts subtly toward contentment -- worries recede slightly, irritations lose their edge, and there is a modest sense of well-being that, while far from euphoric, represents a genuine improvement over baseline. Conversation flows a touch more easily. The body relaxes into its seat with a quiet gratitude.
Physically, the experience is unremarkable by opioid standards. There may be mild nausea, a faint dizziness that passes quickly, and a slight constriction of the pupils. The opioid itch is largely absent or so faint as to be ignorable. Breathing remains essentially normal. The body feels slightly heavy but not immobilized -- you can move through the world with reasonable functionality, though there is a preference for stillness, for letting gravity do its work. Pain relief is present but limited, adequate for mild to moderate discomfort but insufficient for anything more demanding.
The duration stretches to four or five hours, though the peak itself is shorter, lasting perhaps two hours before beginning its gentle decline. The plateau has a flat, undramatic quality -- the experience holds steady without intensifying, a reliable but unspectacular companion. There is something almost forgettable about the peak, a quality of quiet competence that does its job without calling attention to itself.
The offset mirrors the onset in its gentleness. The warmth recedes gradually, so slowly that the return to baseline feels more like a natural transition than a loss. There is no crash, no rebound discomfort. A mild residual drowsiness may linger for an hour or two, and sleep comes easily if pursued. The overall impression is of a compound that operates within narrow parameters -- effective within its range, unpretentious, and fundamentally gentle.
A distinct decrease in hunger and desire to eat, ranging from reduced interest in food to complete disinterest or even physical revulsion at the thought of eating. This effect can persist for many hours beyond the primary experience.
ConstipationA slowing or cessation of bowel movements resulting in difficulty passing stool, commonly caused by opioid receptor activation in the gastrointestinal tract and notoriously resistant to tolerance development.
Cough suppressionA decreased desire and need to cough, medically known as antitussive action, which can also allow inhalation of larger amounts of smoke without triggering the cough reflex.
Decreased libidoDecreased libido is a diminished interest in and desire for sexual activity, commonly caused by substances that suppress dopaminergic reward signaling, dampen emotional responsiveness, or induce sedation.
DiarrheaDiarrhea is the occurrence of frequent, loose, or watery bowel movements as a side effect of certain psychoactive substances, resulting from either direct GI irritation or pharmacological alterations to gut motility and fluid absorption.
Difficulty urinatingDifficulty urinating, also known as urinary retention, is the experience of being unable to easily pass urine despite a full bladder, commonly caused by stimulant, opioid, and anticholinergic substances that affect bladder muscle control.
DizzinessA sensation of spinning, swaying, or lightheadedness that impairs balance and spatial orientation, often accompanied by nausea and difficulty standing or walking steadily.
HeadacheA painful sensation of pressure, throbbing, or aching in the head that can range from a dull background discomfort to a debilitating pounding that dominates awareness. Substance-induced headaches may occur during the acute effects, during the comedown, or as a rebound symptom hours to days after use.
Increased heart rateA noticeable acceleration of heartbeat that can range from a subtle awareness of one's pulse to a forceful, rapid pounding felt throughout the chest, neck, and temples. This effect is among the most commonly reported physiological responses to psychoactive substances and often accompanies stimulation, anxiety, or physical exertion during intoxication.
ItchinessA persistent, diffuse urge to scratch the skin that arises without any external irritant, most commonly caused by opioid-induced histamine release, ranging from a mild tingling to an intense, widespread crawling sensation across the body.
Motor control lossA distinct decrease in the ability to control one's physical body with precision, balance, and coordination, ranging from minor clumsiness to complete inability to walk.
NauseaAn uncomfortable sensation of queasiness and stomach discomfort that may or may not lead to vomiting, often occurring during the onset phase of many substances.
Orgasm suppressionOrgasm suppression (anorgasmia) is the difficulty or complete inability to achieve orgasm despite adequate sexual stimulation, commonly caused by opioids, dissociatives, SSRIs, and stimulants through mechanisms including tactile suppression, serotonergic excess, and altered CNS signaling.
Pain reliefA suppression of negative physical sensations such as aches and pains, ranging from dulled awareness of discomfort to complete inability to perceive pain.
Physical euphoriaAn intensely pleasurable bodily sensation that can manifest as waves of warmth, tingling electricity, or a full-body orgasmic glow radiating outward from the core. This effect is often described as one of the most rewarding physical sensations available through psychoactive substances and is a primary driver of the recreational appeal of many substance classes.
Pupil constrictionA visible narrowing of the pupil diameter (miosis) that reduces the size of the dark center of the eye to a small pinpoint. This effect is one of the most reliable physical indicators of opioid intoxication and is often the first sign noticed by medical professionals and observers when assessing someone under the influence of opioids or certain other substance classes.
Respiratory depressionA dangerous slowing and shallowing of breathing that can progress from barely noticeable reductions in respiratory rate to life-threatening cessation of breathing. This is the primary mechanism of death in opioid overdoses and represents one of the most critical safety concerns across all of psychopharmacology.
SedationA state of deep physical and mental calming that manifests as a progressive desire to remain still, lie down, and eventually drift toward sleep. Sedation ranges from a gentle drowsy relaxation to a heavy, irresistible pull into unconsciousness where maintaining wakefulness becomes a losing battle against the body's insistence on shutdown.
SeizureUncontrolled brain electrical activity causing convulsions and loss of consciousness -- a life-threatening medical emergency requiring immediate help.
Serotonin syndromeSerotonin syndrome is a potentially fatal medical emergency caused by excessive serotonergic activity in the central and peripheral nervous systems, typically resulting from combining multiple serotonin-elevating substances, and manifesting as a dangerous triad of neuromuscular hyperactivity, autonomic dysfunction, and altered mental status.
Spontaneous physical movementsSpontaneous physical movements are involuntary, seemingly random yet patterned body movements — twitches, swaying, gestures, or full-body undulations — that appear to arise from and correspond to the individual's internal cognitive and sensory experience rather than from conscious motor commands.
A complete or partial inability to form new memories or recall existing ones during and after substance use, ranging from minor gaps in recollection to total blackouts encompassing hours of experience.
AnxietyIntense feelings of apprehension, worry, and dread that can range from a subtle background unease to overwhelming panic attacks with a sense of impending doom, often amplified by the substance's intensification of one's existing mental state.
Anxiety suppressionA partial to complete suppression of anxiety and general unease, producing a calm, relaxed mental state free from worry. This can range from subtle tension relief to a profound sense of inner peace and emotional security.
Cognitive euphoriaA cognitive and emotional state of intense well-being, elation, happiness, and joy that manifests as a profound mental contentment and positive outlook. This ranges from gentle feelings of optimism and warmth to overwhelming bliss that pervades all thoughts and perceptions.
Compulsive redosingAn overwhelming, difficult-to-resist urge to continuously take more of a substance in order to maintain or intensify its effects, often overriding rational judgment and self-control.
ConfusionAn impairment of abstract thinking marked by a persistent inability to grasp or comprehend concepts and situations that would normally be perfectly understandable during sobriety.
DepressionA persistent state of low mood, emotional numbness, hopelessness, and diminished interest or pleasure in activities, often occurring during comedowns, withdrawal, or as a prolonged after-effect of substance use.
Dream potentiationEnhanced dream vividness, complexity, and recall, often occurring as REM rebound after discontinuing REM-suppressing substances.
SleepinessA progressive onset of drowsiness, heaviness, and the desire to sleep that pulls the individual toward rest with increasing insistence. The eyelids feel weighted, the body sinks into whatever surface supports it, cognitive activity winds down into a pleasant fog, and the transition from waking consciousness toward sleep begins to feel not only appealing but inevitable.
Dextropropoxyphene can produce 21 physical effects including respiratory depression, appetite suppression, pupil constriction, cough suppression, and 17 more.
Dextropropoxyphene produces 9 cognitive effects including compulsive redosing, anxiety suppression, cognitive euphoria, depression, and 5 more.